DOCSLIB.ORG

Late-Breaking Supplement

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Late-Breaking Supplement 2017 Annual Meeting Abstract Supplement LATE-BREAKING ABSTRACT SUBMISSIONS These abstracts are available via the Mobile Event App, Online Planner, and a downloadable PDF from the SOT website. All Late-Breaking Abstracts are presented on Thursday, March 16, from 8:30 am–11:45 am. www.toxicology.org THURSDAY POSTER SESSION MAP March 16, 2017—8:30 AM to 11:45 AM—Hall A Poster Set Up—7:30 AM to 8:30 AM Late-Breaking Poster #s: P196-P540 (highlighted in gray) P540 P539 P538 P537 P533 P534 P535 P536 P532 P531 P530 P529 P528 P527 P526 P525 P524 P523 P522 P521 P520 P519 P518 P517 P516 P515 P497 P498 P499 P500 P501 P502 P503 P504 P505 P506 P507 P508 P509 P510 P511 P512 P513 P514 P496 P495 P494 P493 P492 P491 P490 P489 P488 P487 P486 P485 P484 P483 P482 P481 P480 P479 P461 P462 P463 P464 P465 P466 P467 P468 P469 P470 P471 P472 P473 P474 P475 P476 P477 P478 P460 P459 P458 P457 P456 P455 P454 P453 P452 P451 P450 P449 P448 P447 P446 P445 P444 P443 P425 P426 P427 P428 P429 P430 P431 P432 P433 P434 P435 P436 P437 P438 P439 P440 P441 P442 P424 P423 P422 P421 P420 P419 P418 P417 P416 P415 P414 P413 P412 P411 P410 P409 P408 P407 P389 P390 P391 P392 P393 P394 P395 P396 P397 P398 P399 P400 P401 P402 P403 P404 P405 P406 P388 P387 P386 P385 P384 P383 P382 P381 P380 P379 P378 P377 P376 P375 P374 P373 P372 P371 P353 P354 P355 P356 P357 P358 P359 P360 P361 P362 P363 P364 P365 P366 P367 P368 P369 P370 P352 P351 P350 P349 P348 P347 P346 P345 P344 P343 P342 P341 P340 P339 P338 P337 P336 P335 P317 P318 P319 P320 P321 P322 P323 P324 P325 P326 P327 P328 P329 P330 P331 P332 P333 P334 P316 P315 P314 P313 P312 P311 P310 P309 P308 P307 P306 P305 P304 P303 P302 P301 P300 P299 P281 P282 P283 P284 P285 P286 P287 P288 P289 P290 P291 P292 P293 P294 P295 P296 P297 P298 P280 P279 P278 P277 P276 P275 P274 P273 P272 P271 P270 P269 P268 P267 P266 P265 P264 P263 P245 P246 P247 P248 P249 P250 P251 P252 P253 P254 P255 P256 P257 P258 P259 P260 P261 P262 P244 P243 P242 P241 P240 P239 P238 P237 P236 P235 P234 P233 P232 P231 P230 P229 P228 P227 P209 P210 P211 P212 P213 P214 P215 P216 P217 P218 P219 P220 P221 P222 P223 P224 P225 P226 P208 P207 P206 P205 P204 P203 P202 P201 P200 P199 P198 P197 P196 P195 P194 P193 P192 P191 P173 P174 P175 P176 P177 P178 P179 P180 P181 P182 P183 P184 P185 P186 P187 P188 P189 P190 P172 P171 P170 P169 P168 P167 P166 P165 P164 P163 P162 P161 P160 P159 P158 P157 P156 P155 P137 P138 P139 P140 P141 P142 P143 P144 P145 P146 P147 P148 P149 P150 P151 P152 P153 P154 P136 P135 P134 P133 P132 P131 P130 P129 P128 P127 P126 P125 P124 P123 P122 P121 P120 P119 P101 P102 P103 P104 P105 P106 P107 P108 P109 P110 P111 P112 P113 P114 P115 P116 P117 P118 Entrance Photography and video in all poster sessions is prohibited without the consent of the poster presenter(s)/author(s). Please respect your colleagues' rights to privacy. Thursday, March 16, Late-Breaking Poster Session by Location Session Title Abstract #s Poster Board #s Late-Breaking Poster Session 1 Author Attended: 8:30 AM-10:00 AM Emerging Technologies 3227-3230 P196-P199 Biological Modeling 3231-3235 P200-P204 Epidemiology and Public Health 3236-3240 P205-P209 Exposure Assessment/Biomonitoring 3241-3249 P210-P218 Regulation/Policy; Risk Assessment 3250-3267 P219-P236 Safety Assessment: Non-Pharm./Drug Development/Drug Discovery 3268-3288 P237-P257 Immunotoxicity; Inflammation 3289-3298 P258-P267 Late-Breaking Poster Session 2 Author Attended: 10:00 AM-11:45 AM Food Safety/Nutrition; Natural Products 3299-3315 P269-P285 Air Pollution Toxicology 3316-3322 P286-P292 Respiratory Toxicology 3323-3334 P293-P304 Persistent Organic Pollutants (POPs) 3335-3341 P305-P311 Cardiovascular Toxicology/Hemodynamics 3342-3348 P312-P318 Carcinogenesis and Oxidative Injury/Redox Biology 3349-3355 P319-P325 Late-Breaking Poster Session 3 Author Attended: 8:30 AM-10:00 AM Biomarkers 3356-3361 P327-P332 Cell Death/Apoptosis; Autoimmunity/Hypersensitivity; Bioinformatics 3362-3365 P333-P336 Animal Models 3366-3369 P337-P340 Alternatives to Mammalian Models 3370-3377 P341-P348 Chemical and Biological Weapons; Ecotoxicology 3378-3389 P349-P360 Computational Toxicology and Data Integration 3390-3398 P361-P369 Late-Breaking Poster Session 4 Author Attended: 10:00 AM-11:45 AM Clinical and Translational Toxicology 3399-3401 P371-P373 Developmental/Juvenile Toxicology; Reproductive Toxicology 3402-3421 P374-P393 Endocrine Toxicology 3422-3430 P394-P402 Epigenetics 3431-3433 P403-P405 Medical Devices 3434-3437 P406-P409 Education, Ethical, Legal, and Social Issues; Systems Biology and Toxicology 3438-3444 P410-P416 Late-Breaking Poster Session 5 Author Attended: 8:30 AM-10:00 AM Metals 3445-3458 P418-P431 Neurotoxicity: Metals, Pesticides 3459-3467 P432-P440 Neurodegenerative Disease 3468-3472 P441-P445 Neurotoxicity: Developmental, General 3473-3487 P446-P460 Ocular Toxicology; Pesticides 3488-3497 P461-P470 Stem Cell Biology and Toxicology 3498-3503 P471-P476 Late-Breaking Poster Session 6 Author Attended: 10:00 AM-11:45 AM Disposition/Pharmacokinetics 3504-3508 P479-P483 Gene Regulation/Signal Transduction; Genotoxicity/DNA Repair 3509-3521 P484-P496 Kidney; Liver; Skin 3522-3535 P497-P510 Mixtures 3536-3539 P511-P514 Nanotoxicology 3540-3546 P515-P521 Pharmacogenomics/Genetic Polymorphisms; Receptors 3547-3549 P522-P524 General Toxicology 3550-3563 P525-P538 i TOPIC ABSTRACT #s POSTER BOARD #s Session Title Late-Breaking Poster Air Pollution Toxicology 3316-3322 P286-P292 Session 2 Late-Breaking Poster Alternatives to Mammalian Models 3370-3377 P341-P348 Session 3 Late-Breaking Poster Animal Models 3366-3369 P337-P340 Session 3 Late-Breaking Poster Autoimmunity/Hypersensitivity 3364 P335 Session 3 Late-Breaking Poster Bioinformatics 3365 P336 Session 3 Late-Breaking Poster Biological Modeling 3231-3235 P200-P204 Session 1 Late-Breaking Poster Biomarkers 3356-3361 P327-P332 Session 3 Late-Breaking Poster Carcinogenesis 3349-3355 P319-P325 Session 2 Late-Breaking Poster Cardiovascular Toxicology/Hemodynamics 3342-3348 P312-P318 Session 2 Late-Breaking Poster Cell Death/Apoptosis 3362-3363 P333-P334 Session 3 Late-Breaking Poster Chemical and Biological Weapons 3378-3386 P349-P357 Session 3 Late-Breaking Poster Clinical and Translational Toxicology 3399-3401 P371-P373 Session 4 Computational Toxicology and Data Late-Breaking Poster Integration 3390-3398 P361-P369 Session 3 Late-Breaking Poster Developmental and Juvenile Toxicology 3402-3412 P374-P384 Session 4 Late-Breaking Poster Disposition/Pharmacokinetics 3504-3508 P479-P483 Session 6 Late-Breaking Poster Ecotoxicology 3387-3389 P358-P360 Session 3 Late-Breaking Poster Education, Ethical, Legal, and Social Issues 3438-3439 P410-P411 Session 4 Late-Breaking Poster Emerging Technologies 3227-3230 P196-P199 Session 1 Late-Breaking Poster Endocrine Toxicology 3422-3430 P394-P402 Session 4 Late-Breaking Poster Epidemiology and Public Health 3236-3240 P205-P209 Session 1 Late-Breaking Poster Epigenetics 3431-3433 P403-P405 Session 4 Late-Breaking Poster Exposure Assessment/Biomonitoring 3241-3249 P210-P218 Session 1 ii TOPIC ABSTRACT #s POSTER BOARD #s Session Title Late-Breaking Poster Gene Regulation/Signal Transduction 3509-3510 P484-P485 Session 6 Late-Breaking Poster General Toxicology 3550-3563 P525-P538 Session 6 Late-Breaking Poster Genotoxicity/DNA Repair 3511-3521 P486-P496 Session 6 Late-Breaking Poster Inflammation 3297-3298 P266-P267 Session 1 Late-Breaking Poster Immunotoxicity 3289-3296 P258-P265 Session 1 Late-Breaking Poster Kidney 3522-3525 P497-P500 Session 6 Late-Breaking Poster Liver 3526-3533 P501-P508 Session 6 Late-Breaking Poster Medical Devices 3434-3437 P406-P409 Session 4 Late-Breaking Poster Metals 3445-3458 P418-P431 Session 5 Late-Breaking Poster Mixtures 3536-3539 P511-P514 Session 6 Late-Breaking Poster Nanotoxicology 3540-3546 P515-P521 Session 6 Late-Breaking Poster Natural Products 3312-3315 P282-P285 Session 2 Late-Breaking Poster Neurotoxicity/Neurodegenerative Disease 3459-3487 P432-P460 Session 5 Late-Breaking Poster Ocular Toxicology 3488-3489 P461-P462 Session 5 Late-Breaking Poster Oxidative Injury and Redox Biology 3354-3355 P324-P325 Session 2 Late-Breaking Poster Persistent Organic Pollutants (POPs) 3335-3341 P305-P311 Session 2 Late-Breaking Poster Pesticides 3490-3497 P463-P470 Session 5 Pharmacogenomics/Genetic Late-Breaking Poster Polymorphisms 3547-3548 P522-P523 Session 6 Late-Breaking Poster Receptors 3549 P524 Session 6 Late-Breaking Poster Regulation/Policy 3250-3253 P219-P222 Session 1 Late-Breaking Poster Reproductive Toxicology 3413-3421 P385-P393 Session 4 iii TOPIC ABSTRACT #s POSTER BOARD #s Session Title Late-Breaking Poster Respiratory Toxicology 3323-3334 P293-P304 Session 2 Late-Breaking Poster Risk Assessment 3254-3267 P223-P236 Session 1 Late-Breaking Poster Safety Assessment: Non-Pharmaceutical 3268-3271 P237-P240 Session 1 Safety Assessment: Pharmaceutical-Drug Late-Breaking Poster Development and Drug Discovery 3272-3288 P241-P257 Session 1 Late-Breaking Poster Skin 3534-3535 P509-P510 Session 6 Late-Breaking Poster Stem Cell Biology and Toxicology 3498-3503 P471-P476 Session 5 Late-Breaking Poster Systems Biology and Toxicology 3440-3444 P412-P416 Session 4 iv 2017 Society of Toxicology Annual Meeting Late-Breaking Abstracts ABSTRACT NUMBER : 3227 Poster Board Number : P196 TITLE : The GARD Platform for Potency Assessment of Skin Sensitizing Chemicals AUTHORS (FIRST INITIAL, LAST NAME) AND INSTITUTIONS : A. Forreryd 1, K. Zeller 1, T. Lindberg 1, R. Gradin 2, A. Chawade 1, M. Lindstedt 1. 1Lund University, Lund, Sweden; 2SenzaGen, Lund, Sweden. KEYWORDS : Immunotoxicity; Potency, Chemical Testing ABSTRACT : Allergic Contact Dermatitis (ACD) constitutes a major problem for 15-20% of the population and develops upon repeated exposure to skin sensitizing chemicals.
Load more

Recommended publications
  • Neurological and Neuroimaging Signs of Reversible Parkinsonism Associated with Manganese Exposure
    [Downloaded free from http://www.neurologyindia.com on Thursday, March 13, 2014, IP: 202.177.173.189] || Click here to download free Android application for this journal Editorial Neurological and neuroimaging signs of reversible Parkinsonism associated with manganese exposure Basant K. Puri Department of Imaging, Hammersmith Hospital, London, UK Address for correspondence: Prof. Basant K. Puri, Department of Imaging, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK. E-mail: [email protected] Received : 03-02-2014 Review completed : 03-02-2014 Accepted : 03-02-2014 In this month’s issue of Neurology India, Han The heavy metal manganese (atomic number 25, relative et al. present an unusual case entitled ‘Reversal atomic mass 54.938) lies in group 7 of the periodic table of pallidal magnetic resonance imaging (MRI) T1 and has a natural abundance in the earth’s crust that, hyperintensity in a welder presenting as reversible among the heavy metals, is second only to that of iron, parkinsonism’.[1] Parkinsonism is a syndrome of multiple with which it is roughly similar in terms of many of its different etiologies and among the toxic causes of physical and chemical properties (although manganese is parkinsonism are alcohol (ethanol) withdrawal, methanol, harder and more brittle but less refractory).[5] It has one of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrodine, inhalant the highest industrial uses of all metals, being important in abuse, metals (including manganese, iron and copper), the production of steel and batteries, in water
    [Show full text]
  • Manganese Toxicity May Appear Slowly Over Months and Years
    MANGANESE 11 2. RELEVANCE TO PUBLIC HEALTH 2.1 BACKGROUND AND ENVIRONMENTAL EXPOSURES TO MANGANESE IN THE UNITED STATES Manganese is a naturally occurring element and an essential nutrient. Comprising approximately 0.1% of the earth’s crust, it is the twelfth most abundant element and the fifth most abundant metal. Manganese does not exist in nature as an elemental form, but is found mainly as oxides, carbonates, and silicates in over 100 minerals with pyrolusite (manganese dioxide) as the most common naturally-occurring form. As an essential nutrient, several enzyme systems have been reported to interact with or depend on manganese for their catalytic or regulatory function. As such, manganese is required for the formation of healthy cartilage and bone and the urea cycle; it aids in the maintenance of mitochondria and the production of glucose. It also plays a key role in wound-healing. Manganese exists in both inorganic and organic forms. An essential ingredient in steel, inorganic manganese is also used in the production of dry-cell batteries, glass and fireworks, in chemical manufacturing, in the leather and textile industries and as a fertilizer. The inorganic pigment known as manganese violet (manganese ammonium pyrophosphate complex) has nearly ubiquitous use in cosmetics and is also found in certain paints. Organic forms of manganese are used as fungicides, fuel-oil additives, smoke inhibitors, an anti-knock additive in gasoline, and a medical imaging agent. The average manganese soil concentrations in the United States is 40–900 mg/kg; the primary natural source of the manganese is the erosion of crustal rock.
    [Show full text]
  • Manganese and Its Compounds: Environmental Aspects
    This report contains the collective views of an international group of experts and does not necessarily represent the decisions or the stated policy of the United Nations Environment Programme, the International Labour Organization, or the World Health Organization. Concise International Chemical Assessment Document 63 MANGANESE AND ITS COMPOUNDS: ENVIRONMENTAL ASPECTS First draft prepared by Mr P.D. Howe, Mr H.M. Malcolm, and Dr S. Dobson, Centre for Ecology & Hydrology, Monks Wood, United Kingdom The layout and pagination of this pdf file are not identical to the document in print Corrigenda published by 12 April 2005 have been incorporated in this file Published under the joint sponsorship of the United Nations Environment Programme, the International Labour Organization, and the World Health Organization, and produced within the framework of the Inter-Organization Programme for the Sound Management of Chemicals. World Health Organization Geneva, 2004 The International Programme on Chemical Safety (IPCS), established in 1980, is a joint venture of the United Nations Environment Programme (UNEP), the International Labour Organization (ILO), and the World Health Organization (WHO). The overall objectives of the IPCS are to establish the scientific basis for assessment of the risk to human health and the environment from expos ure to chemicals, through international peer review processes, as a prerequisite for the promotion of chemical safety, and to provide technical assistance in strengthening national capacities for the sound management
    [Show full text]
  • 10Neurodevelopmental Effects of Childhood Exposure to Heavy
    Neurodevelopmental E¤ects of Childhood Exposure to Heavy Metals: 10 Lessons from Pediatric Lead Poisoning Theodore I. Lidsky, Agnes T. Heaney, Jay S. Schneider, and John F. Rosen Increasing industrialization has led to increased exposure to neurotoxic metals. By far the most heavily studied of these metals is lead, a neurotoxin that is particularly dangerous to the developing nervous system of children. Awareness that lead poison- ing poses a special risk for children dates back over 100 years, and there has been increasing research on the developmental e¤ects of this poison over the past 60 years. Despite this research and growing public awareness of the dangers of lead to chil- dren, government regulation has lagged scientific knowledge; legislation has been in- e¤ectual in critical areas, and many new cases of poisoning occur each year. Lead, however, is not the only neurotoxic metal that presents a danger to children. Several other heavy metals, such as mercury and manganese, are also neurotoxic, have adverse e¤ects on the developing brain, and can be encountered by children. Al- though these other neurotoxic metals have not been as heavily studied as lead, there has been important research describing their e¤ects on the brain. The purpose of the present chapter is to review the neurotoxicology of lead poisoning as well as what is known concerning the neurtoxicology of mercury and manganese. The purpose of this review is to provide information that might be of some help in avoiding repeti- tion of the mistakes that were made in attempting to protect children from the dan- gers of lead poisoning.
    [Show full text]
  • Da UNIVERSIDADE DA BEIRA INTERIOR
    da UNIVERSIDADE DA BEIRA INTERIOR ANALYSIS OF ORGANOPHOSPHOROUS PESTICIDES IN POSTMORTEM BIOLOGICAL FLUIDS RAQUEL HELENA CARVALHO SILVA RAPOSO Covilhã, 2009 I UNIVERSIDADE DA BEIRA INTERIOR ANALYSIS OF ORGANOPHOSPHOROUS PESTICIDES IN POSTMORTEM BIOLOGICAL FLUIDS Dissertação apresentada à Universidade da Beira Interior para a obtenção do Grau de Mestre em Bioquímica RAQUEL HELENA CARVALHO SILVA RAPOSO Covilhã, 2009 II Trabalho elaborado sob a supervisão e orientação científica do Mestre Mário João Dias, Director do Serviço de Toxicolgia Forense da Delegação Sul do Instituto Nacional de Medicina Legal e da Prof. Doutora María Eugenia Gallardo Alba, Faculdade de Ciências da Saúde da Universidade da Beira Interior III TABLE OF CONTENTS List of Figures ........................................................................................................................................... VI List of Tables .......................................................................................................................................... VIII Abbreviations ............................................................................................................................................ X Abstract................................................................................................................................................... - 1 - Resumo ................................................................................................................................................... - 3 - Justification and Objectives
    [Show full text]
  • INCORPORATING LOW-DOSE EPIDEMIOLOGY DATA in a CHLORPYRIFOS RISK ASSESSMENT Julie E
    Dose-Response: An International Journal Volume 11 | Issue 2 Article 8 6-2013 INCORPORATING LOW-DOSE EPIDEMIOLOGY DATA IN A CHLORPYRIFOS RISK ASSESSMENT Julie E. Goodman Gradient, Cambridge, MA Robyn L. Prueitt Gradient, Cambridge, MA Lorenz R. Rhomberg Gradient, Cambridge, MA Follow this and additional works at: https://scholarworks.umass.edu/dose_response Recommended Citation Goodman, Julie E.; Prueitt, Robyn L.; and Rhomberg, Lorenz R. (2013) "INCORPORATING LOW-DOSE EPIDEMIOLOGY DATA IN A CHLORPYRIFOS RISK ASSESSMENT," Dose-Response: An International Journal: Vol. 11 : Iss. 2 , Article 8. Available at: https://scholarworks.umass.edu/dose_response/vol11/iss2/8 This Article is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Dose-Response: An International Journal by an authorized editor of ScholarWorks@UMass Amherst. For more information, please contact [email protected]. Goodman et al.: Low-Dose Epidemiology Data in a Chlorpyrifos Risk Assessment Dose-Response, 11:207–219, 2013 Formerly Nonlinearity in Biology, Toxicology, and Medicine Copyright © 2013 University of Massachusetts ISSN: 1559-3258 DOI: 10.2203/dose-response.12-022.Goodman INCORPORATING LOW-DOSE EPIDEMIOLOGY DATA IN A CHLORPYRIFOS RISK ASSESSMENT Julie E. Goodman, Robyn L. Prueitt, and Lorenz R. Rhomberg ᮀ Gradient, Cambridge, MA ᮀ USEPA assessed whether epidemiology data suggest that fetal or early-life chlorpyrifos exposure causes neurodevelopmental effects and, if so, whether they occur at exposures below those causing the current most sensitive endpoint, 10% inhibition of blood acetyl- cholinesterase (AChE). We previously conducted a hypothesis-based weight-of-evidence analysis and found that a proposed causal association between chlorpyrifos exposure and neurodevelopmental effects in the absence of AChE inhibition does not have a substantial basis in existing animal or in vitro studies, and there is no plausible basis for invoking such effects in humans at their far lower exposure levels.
    [Show full text]
  • Mother/Child Organophosphate and Pyrethroid Distributions T ⁎ Natalia Bravoa, Joan O
    Environment International 134 (2020) 105264 Contents lists available at ScienceDirect Environment International journal homepage: www.elsevier.com/locate/envint Mother/child organophosphate and pyrethroid distributions T ⁎ Natalia Bravoa, Joan O. Grimalta, , Darja Mazejb, Janja Snoj Tratnikb,c, Dimosthenis Andreas Sarigiannisd, Milena Horvatb,c a Institute of Environmental Assessment and Water Research (IDAEA-CSIC), Department of Environmental Chemistry, Jordi Girona, 18, 08034 Barcelona, Catalonia, Spain b Department of Environmental Sciences, Jožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia c International Postgraduate School Jožef Stefan, Jamova cesta 39, 1000 Ljubljana, Slovenia d Environmental Engineering Laboratory, Department of Chemical Engineering and HERACLES Research Centre on the Exposome and Health, Centre for Interdisciplinary Research and Innovation, Aristotle University of Thessaloniki University Campus, Bldg. D, Rm 201, 54124 Thessaloniki, Greece ARTICLE INFO ABSTRACT Handling Editor: Adrian Covaci The present study reports one of the few cases in which organophosphate (OP) and pyrethroid (PYR) pesticide Keywords: human exposure is evaluated in family contexts by the analysis of mother/child pair samples. Urinary con- Organophosphorus pesticides centrations of 6 organic metabolites of organophosphates and 2 pyrethroids were measured in mothers and their Pyrethroids 7-to 8-year-old children (n = 168) in a general population from the central area of Slovenia. The results were Human Biomonitoring adjusted for specific gravity and creatinine. Children The most abundant OP metabolite in children was 4-nitrophenol (PNP) (median 0.7 ng/ml) and in mothers Women (0.45 ng/ml), representing parathion exposure. 3-Phenoxibenzoic acid (3-PBA) (0.26 ng/ml), the general me- Child-mother pairs tabolite of pyrethroids, and 3,5,6-trichloro-2-pyridinol (TCPY) (0.16 ng/ml; chlorpyriphos) were the second most abundant compounds in children and mothers, respectively.
    [Show full text]
  • Estimation of Daily Intake and Risk Assessment of Organophosphorus Pesticides Based on Biomonitoring Data
    Food and Chemical Toxicology 123 (2019) 57–71 Contents lists available at ScienceDirect Food and Chemical Toxicology journal homepage: www.elsevier.com/locate/foodchemtox Review Estimation of daily intake and risk assessment of organophosphorus T pesticides based on biomonitoring data – The internal exposure approach Ioanna Katsikantamia,b, Claudio Colosioc, Athanasios Alegakisb, Manolis N. Tzatzarakisb, ∗ Elena Vakonakib, Apostolos K. Rizosa, Dimosthenis A. Sarigiannisd,e,f, Aristides M. Tsatsakisb, a Department of Chemistry, University of Crete, Foundation for Research and Technology-Hellas, FORTH-IESL, GR-71003, Heraklion, Crete, Greece b Laboratory of Toxicology, Medical School, University of Crete, GR-71003, Heraklion, Crete, Greece c Department of Occupational and Environmental Health of the University of Milan, International Centre for Rural Health of the University Hospital San Paolo, S. Paolo Hospital Unit, Via San Vigilio 43, 20142 Milan, Italy d Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Greece e HERACLES Research Centre on the Exposome and Health, Centre for Interdisciplinary Research and Innovation (KEDEK), Aristotle University of Thessaloniki, Greece f Environmental Health Engineering, Institute for Advanced Study IUSS, Pavia, Italy ARTICLE INFO ABSTRACT Keywords: Human exposure to pesticides can be estimated through different approaches. The approach adopted in this Biomonitoring study is based on internal dose measures. Studies published during 2001 and 2017 were collected from PubMed Dialkyl phosphates and Scopus databases, filtered and organized. The intake of parent compounds is estimated based on theurinary Estimated daily intake excretion of different OP metabolites applying a mathematical model previously used for similar purposes. Once Health effects defined an Estimated Daily Intake (EDI), risk assessment is performed through comparison with specific Organophosphorus pesticides guideline values and hazard index (HI) is calculated to assess cumulative health risk.
    [Show full text]
  • Manganese Exposure and Toxicity
    tion Ef llu fec o ts P f & o l C a o n n r Mirmohammadi, J Pollut Eff Cont 2014, 2:2 t r u o o l Journal of Pollution Effects & Control J DOI: 10.4172/2375-4397.1000116 ISSN: 2375-4397 ReviewResearch Article Article OpenOpen Access Access Manganese Exposure and Toxicity Seyedtaghi Mirmohammadi* Department of Occupational Health, Faculty of Health, Mazandaran University of Medical Sciences, Mazandaran, Sari, Iran Abstract One of the main essential elements for human is Manganese (Mn). Furthermore Mn is a row material for many king of ferrous foundry and there is a working exposure to Mn for workers in the workplaces. High exposure to Mn can result in increase in human tissues levels and neurological effects. Though, there should be some threshold limit value for Mn exposure related to adverse effects may occur and increase with higher exposures further than threshold limit. Conclusions from scientific literatures related to Mn toxicity revealed that this pollutant can effect on brain system and create some neurological disorders or neurological endpoints which measured in many of the occupational health assessments. Many researches have tried to show a relationship regards to biomarkers with neurological effects, such as neurological changes or magnetic resonance imaging (MRI) changes have not been founded for Mn. More precise study need for Mn risk assessment for industrial pollution exposure and it will be used to recognize situations that may guide to understand Mn accumulation on brain and Mn metabolism in different exposed workers. Workplace evaluations for Mn will prepare valuable scientific information for the development of more scientifically sophisticated guidelines, regulations and recommendations for future study and for Mn occupational toxicity control and exposure prevention in the related workplaces.
    [Show full text]
  • Winter 2007–2008
    Pesticides and You News from Beyond Pesticides: Protecting Health and the Environment with Science, Policy and Action Volume 27, Number 4 Winter 2007-2008 Facing Scientifi c Realities, Debunking the “Dose Makes the Poison” Myth How Safe is Your Bait? Pesticides May Be Labeled as “Nonvolatile,” But Still Release Poisons into the Air Grounding out Grubs: Managing grubs with prevention and least-toxic strategies The Secret History of the War on Cancer Letter from Washington Danger at (Really) Low Dose Mo�vates changes that reject the use of toxic chemicals arm resul�ng from really low dose exposure to toxic chemicals can be measured in the air, with the excep�on of boric acid, which is now accepted in scien�fic circles. However, the pes�cide is commonly found in bait formula�ons. With the science on low Hregulatory process s�ll does not reflect the science, nor does level exposure and poten�al adverse impact, we know why there it comply with a 1996 statutory requirement that the agency have ought to be concern, especially when the chemical is placed for long in place by now a protocol for evalua�ng pes�cides that may be periods in and around the perimeter of a room in a sealed indoor endocrine disruptors, known to wreak havoc at miniscule doses in environment. Our ar�cle sheds some important light on this topic. developing organ systems. More data emerges year by year. When we do not have all the answers Lab experiments link exposure to brain effects This discussion adds important weight to the already heavy support In this issue of PAY, we print a talk given by Warren Porter, Ph.D., for the precau�onary approach to pest management.
    [Show full text]
  • Alberta Environment
    Chemical Fact Sheets Manganese, Mn CAS No. 7439-96-5 WHAT IS MANGANESE? Manganese is a gray-pink metal. USES Manganese is used in the manufacture of ceramics, matches, glass, dyes and welding rods. It is a component of steel, steel alloys, cast iron, superalloys & nonferrous alloys, as well as a chemical intermediate for high purity salts. Manganese is used as a purifying & scavenging agent in metal production. SOURCES Manganese is a naturally occurring substance found in many types of rock; it is ubiquitous in the environment and found in low levels in water air, soil, and food. It is commonly found in the environment as a result of its use in the manufacture of the above-noted materials. ENVIRONMENTAL LEVELS AND EXPOSURE Exposure to manganese might include: • Inhaling it in ambient air, particularly near industries involved in the manufacture of manganese-containing materials. Occupational exposure via inhalation is most common. Ambient air concentrations of manganese were not reported in 1997 or 1998 in Alberta. ENVIRONMENTAL FATE AND BEHAVIOUR • Manganese, as an aerosol, may dissolve upon contact with water on a time scale of a few minutes. TOXICITY • Manganese is an element considered essential to human health. • Inhalation of manganese compounds in aerosols or fine dusts may cause "metal fume fever”. MANGANESE Page 1 of 2 • Early symptoms of chronic manganese poisoning may include languor, sleepiness and weakness in the legs. Emotional disturbances such as uncontrollable laughter and a spastic gait with tendency to fall in walking are common in more advanced cases. • Chronic manganese poisoning is not a fatal disease.
    [Show full text]
  • Ip for Persistent Chemicals Found in Breast Milk
    103 5. List of References Aarts JMMJG, Denison MS, Cox MA, et al. 1995. Species-specific antagonism of Ah receptor action by 2,2',5,5'-tetrachloro- and 2,2',3,3',4,4'-hexachlorobiphenyl. Eur J Pharmacol 293:463–474. *Abadin HG, Hibbs BF, Pohl HR. 1997. Breast-feeding exposure of infants to cadmium, lead, and mercury: A public health viewpoint. Toxicol Ind Health 13(4):495–517. Abbott BD, Birnbaum LS. 1989. Cellular alterations and enhanced induction of cleft palate after coadministration of retinoic acid and TCDD. Toxicol Appl Pharmacol 99:287–301. *Abbott BD, Perdew GH, Birnbaum LS. 1994. Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. Toxicol Appl Pharmacol 126:16–25. Abbott BD, Schmid JE, Pitt JA, et al. 1999. Adverse reproductive outcomes in the transgenic Ah receptor-deficient mouse. Toxicol Appl Pharmacol 155:62–70. Abnet CC, Tanguay RL, Heideman W, et al. 1999. Transactivation activity of human, zebrafish, and rainbow trout aryl hydrocarbon receptors expressed in COS-7 cells: Greater insight into species differences in toxic potency of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners. Toxicol Appl Pharmacol 159:41–51. Adami H-O, Lipworth L, Titus-Ernstoff L, et al. 1995. Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control 6:551–566. Ahlborg UG, Lipworth L, Titus-Ernstoff L, et al. 1995. Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: An assessment of the biological and epidemiological evidence. Crit Rev Toxicol 25(6):463–531. *Allen JR, Norback DH. 1976.
    [Show full text]